Myeloproliferative neoplasms: open trials in Portugal

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto

  Registry updated 2026-11-09

• NCT07429266

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  Trial Treatment · Phase 3 · Ono Pharmaceutical Co., Ltd.

  Unidade Local De Saude Da Regiao De Aveiro E.P.E., Aveiro · CCAB Centro Clinico Academico Braga Associacao, Braga · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto · Unidade Local De Saude Do Alto Minho E.P.E., Viana do Castelo

  Registry updated 2026-10-29

• 2023-504724-25-00

  Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis

  Trial Treatment · Phase 3 · Kartos Therapeutics Inc.

  Unidade Local De Saude Da Regiao De Aveiro E.P.E., Aveiro · CCAB Centro Clinico Academico Braga Associacao, Braga · Unidade Local De Saude De Lisboa Ocidental E.P.E., Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude Do Alto Minho E.P.E., Viana do Castelo · Unidade Local de Saúde de Gaia/Espinho, E. P. E, Vila Nova de Gaia

  Registry updated 2026-09-14

• NCT06479135

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  Trial Treatment · Phase 3 · Kartos Therapeutics, Inc.

  Hospital Center of Baixo Vouga -Aveiro Unit - Hospital Infante D. Pedro, Aveiro · Braga Hospital, Braga · Centro Hospitalar Lisboa Norte CHLN EPE - Hospital de Santa Maria, Lisbon · Central Hospital of Western Lisbon, Lisbon · Vila Nova de Gaia Central Hospital, Vila Nova de Gaia

  Registry updated 2025-09-25

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error